Cincinnati Children’s Research

@CincyResearch

As one of the largest pediatric research teams in the United States, our @CincyChildrens discoveries and innovations have changed modern medicine.

Cincinnati, Ohio cincinnatichildrens.org/research Joined May 2024

444 Following 408 Followers 726 Posts

Latest posts 5

Cincinnati Children’s Research @CincyResearch 5d

A new national report from @rarediseasesnet highlights Cincinnati Children’s role in connecting researchers, sharing data and advancing rare disease discoveries. Learn more:
scienceblog.cincinnatichildrens.org/rdcrn-annual-r…
#RDCRN #RareDiseaseResearch

scienceblog.cincinnatichildrens.org Rare Diseases Clinical Research Network Releases First-Ever Annual Report - Research Horizons A new national report highlights Cincinnati Children’s role in connecting researchers, sharing data and advancing rare disease discoveries.

Cincinnati Children’s Research @CincyResearch 5d

Congratulations to the Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR), which has received a $7.7 million, 5-year grant from the NIH to continue research on rare eosinophilic gastrointestinal diseases (EGIDs). @RothenbergLab
scienceblog.cincinnatichildrens.org/nih-renews-fun…

scienceblog.cincinnatichildrens.org NIH Renews Funding for Eosinophilic Gastrointestinal Disease Research Group - Research Horizons NIH funding will support five more years of nationwide research to improve diagnosis, treatment and long-term understanding of rare eosinophilic gastrointestinal diseases.

Cincinnati Children’s Research @CincyResearch Nov 3

In an international Phase III trial across 27 sites, including Cincinnati Children’s, oral infigratinib increased growth velocity in children with achondroplasia versus placebo. Published in @NEJM. Learn more: ow.ly/itLq5103wuO
#Achondroplasia #RareDiseaseResearch

scienceblog.cincinnatichildrens.org Study Reports Positive Results for First Potential Oral Achondroplasia Therapy - Research Horizons A global Phase III trial found that targeting FGFR3 with oral infigratinib improved growth in children with achondroplasia.

Cincinnati Children’s Research @CincyResearch Oct 30

Curiosity, mentorship and cross-disciplinary collaboration helped Tanya Froehlich, MD, MS, turn an unexpected path into a career improving care for children with ADHD. Read her Road to Researcher story: scienceblog.cincinnatichildrens.org/road-to-resear…
#WomenInScience #ADHDAwarenessMonth #WeAreCincyKids

Cincinnati Children’s Research @CincyResearch Oct 29

Cincinnati Children's researcher Nurit P. Azouz, PhD shares an unexpected finding: Complete loss of KLK5 in mice worsened allergic skin inflammation and disrupted barrier function and immunity. Published in @MucosalImmunol. scienceblog.cincinnatichildrens.org/what-klk5-taug…

scienceblog.cincinnatichildrens.org What KLK5 Taught Me About Atopic Dermatitis - Research Horizons Unexpected findings revealed that losing KLK5 worsens allergic skin disease and disrupts barrier function and immunity.